Table 1 Comparison of clinical data between non-fungal infection group and fungal infection group

General data

Age (M (P25,P75), years)

50.0 (38.0,59.0)

59.0 (49.0,67.0)

−7.154

<0.001*

Female (n (%))

1571 (39.5)

106 (59.6)

28.419

<0.001*

BMI (M (P25,P75), kg/m²)

24.8(22.8,27.7)

25.1(22.2,27.4)

−0.06

0.996

DM (n (%))

581 (14.6)

67 (37.6)

71.879

<0.001*

History of malignancy (n (%))

240 (6.0)

64 (36.0)

224.847

<0.001*

Being bedridden (n (%))

95 (2.4)

34 (19.1)

158.133

<0.001*

Immunosuppression (n (%))

26 (0.7)

12 (6.7)

63.104

<0.001*

Preoperative data

Admission HB (M (P25,P75), g/L)

129.0 (117.0, 143.0)

129.0 (116.8, 140.0)

−1.483

0.138

Admission WBC (M (P25,P75),*109/L)

6.6 (5.1, 8.7)

7.6 (5.7, 10.1)

−4.153

<0.001*

Admission Neu (M (P25,P75),*109/L)

4.1 (3.0, 5.6)

4.7 (3.3, 7.3)

−3.197

0.001*

Admission ALB <30 g/L (n (%))

79 (2.0)

13 (7.3)

19.848

<0.001*

Admission ALT (M (P25,P75),U/L)

19.0(13.0, 29.8)

17.0(12.0, 28.3)

−1.397

0.162

Admission AST (M (P25,P75),U/L)

15.0(11.0,19.0)

13.0(8.0, 22.0)

−1.854

0.064

Admission Scr (M (P25,P75),μmoI/L)

74.0 (63.0, 92.0)

74.0 (55.0, 107.3)

−0.576

0.565

Pyuria (n (%))

3234 (81.3)

157 (88.2)

5.354

0.021*

Urinary nitrite (n (%))

129 (3.2)

17 (9.6)

19.979

<0.001*

Urine pH (M (P25,P75))

6.5 (6.0,7.0)

6.5 (6.0, 6.5)

−0.381

0.703

Multiple stones (n (%))

1886 (47.4)

90 (50.6)

0.668

0.414

Maximum stone diameter (M (P25,P75), mm)

10.8 (7.5, 16.5)

10.4 (8.0, 15.3)

−0.410

0.682

PSD (M (P25,P75), HU)

1275.0 (980.0, 1463.0)

1290.5 (1007.0, 1408.0)

−1.393

0.164

SFU grading (n (%))

7.559

0.109

0

644 (16.2)

18 (10.1)

I

805 (20.2)

35 (19.7)

II

1003 (25.2)

50 (28.1)

III

1188 (29.9)

53 (29.8)

IV

336 (8.5)

22 (12.4)

Ureteral Stenting (n (%))

584(14.7)

59(33.1)

44.367

<0.001*

PNS (n (%))

34(0.9)

6(3.4)

11.306

0.006*

Intraoperative data

Operation time (M (P25,P75), min)

53.0(31.0, 75.0)

70.0 (50.0, 111.3)

−6.849

<0.001*

UAS (n (%))

6.191

0.013*

T-UAS

3801(95.6)

177(99.4)

NP-UAS

175(4.4)

1(0.6)

Postoperative data

Fever (n (%))

890 (22.4)

110 (61.8)

149.797

<0.001*

Postoperative WBC (M (P25,P75),*109/L)

7.0 (5.3, 9.2)

7.4 (6.2, 10.1)

−3.338

0.001*

Postoperative Neu (M (P25,P75),*109/L)

5.1 (3.2, 7.1)

6.1 (4.5,8.2)

−5.702

<0.001*

Postoperative Ca (M (P25,P75), mmol/L)

2.3 (2.3, 2.4)

2.3 (2.3,2.4)

−0.744

0.457

CSRF (n (%))

1416(35.6)

73(41.0)

2.158

0.142

Infectious stones (n (%))

1149 (28.9)

54 (30.3)

0.171

0.679

Urethral catheterization duration (M (P25,P75), days)

1.0 (1.0,4.0)

2.0 (1.0,4.0)

−4.105

<0.001*

Stent duration (M (P25,P75), weeks)

4.0 (4.0,8.0)

8.0 (4.0,12.0)

−7.832

<0.001*

Other data

Carbapenem antibiotics use (n (%))

252 (6.3)

94 (52.8)

481.863

<0.001*

Duration of antibiotic therapy (M (P25,P75), days)

4.0 (3.0, 6.0)

8.0 (6.0, 9.0)

−14.565

<0.001*

LOS (M (P25,P75), days)

6.0 (4.0, 8.0)

12.0 (7.0, 14.0)

−13.616

<0.001*